New imaging agent seeks to light up hidden cancer
Diagnosis
Not yet recruiting
This early-stage study is testing a new imaging agent called 111In-ABD147 to see if it can detect metastatic cancer in patients with solid tumors. The agent is designed to attach to a protein called DLL3, which is often found on certain cancer cells. The main goals are to see if …
Phase: EARLY_PHASE1 • Sponsor: Thomas Hope • Aim: Diagnosis
Last updated Mar 30, 2026 14:33 UTC